Modern Organism Cultivation
Looking for the Right Bioprocess Solution?
Our specialists support you throughout the entire bioprocess lifecycle — from system selection and application design to implementation, optimization, and long-term operation. We work closely with you to ensure reliable, compliant, and scalable solutions tailored to your requirements.
Scientific Solutions Start Here
Reach out to discuss innovative approaches for your project.
FAQ — End Products
Applikon bioreactor systems support the production of a wide range of biotechnological end products — including biotherapeutics such as monoclonal antibodies (mAbs), viral vectors, and vaccines, cell and gene therapy products including mRNA, as well as cellular agriculture outputs such as cultivated meat, plant-based food and dairy alternatives, and aroma compounds. From lab-scale research to GMP-compliant commercial production, Resea Biotec provides the right Applikon system for every stage of your bioprocess.
Applikon bioreactor systems are widely used for the production of monoclonal antibodies (mAbs), viral vectors for gene therapy applications, and vaccines — all of which require precise environmental control, GMP compliance, and scalable manufacturing platforms. The Applikon portfolio, including the AppliFlex ST GMP single-use bioreactor and stainless steel production systems, supports both clinical and commercial-scale biotherapeutic manufacturing.
Cell and gene therapy products — including mRNA and cell therapy applications — demand the highest standards of process control, sterility, and scalability. The AppliFlex ST GMP single-use bioreactor is specifically designed for these requirements, offering a fully closed, contamination-free system that meets cGMP standards. Combined with the Livit Flex bioprocess controller, it provides the precise pH, DO, and temperature management critical for consistent therapeutic product quality.
Yes. Applikon bioreactor systems support the full range of cellular agriculture applications — from cultured meat and plant-based dairy alternatives to aroma compounds and flavour ingredients. These emerging applications require the same precision bioprocess control as pharmaceutical manufacturing — precise nutrient feeding, pH and DO regulation, and scalable platforms — all of which the Applikon portfolio delivers, from the MiniBio through to large-scale production systems.
Yes — and this is one of the defining strengths of the Applikon platform. A consistent design philosophy across the MiniBio, glass autoclavable, AppliFlex ST single-use, and stainless steel bioreactors ensures that process parameters developed at small scale transfer reliably to pilot and production scale — without extensive re-optimisation. Whether you are producing biotherapeutics, cell therapy products, or food-tech ingredients, the platform grows with your programme. Contact our specialists to discuss your scale-up pathway.